My #1 Pick for 2021

This year has been interesting to say the very least. It began with a market crash caused by the pandemic. But that crash created a fantastic buying opportunity.

Blue chips and other fantastic stocks could be had at discounts as high as 50%.

But now, as the year is winding down, the markets have seen a strong resurgence…

And cannabis stocks are making headlines once again.

Back in 2018, cannabis stocks were the hot commodity in the stock market. My readers were able to lock in some pretty incredible gains…

Like 101.17% on Aphria (Nasdaq: APHA). Or an incredible 232.17% on Canopy Growth Corp. (Nasdaq: CGC).

Now you have another opportunity for a win like that…

Cannabis stocks jumped in early November on the news of Joe Biden’s victory… and then again later in the month when we heard that both the U.S. House of Representatives and the United Nations would be voting on cannabis regulations.

Pot stocks bounced on the news… even though the Senate is unlikely to go for the Marijuana Opportunity Reinvestment and Expungement Act.

But the fact that the topic of marijuana legalization is reaching the most powerful political entities is very good news.

And I’ve found just the stock to profit from it.

This is an exclusive pick my readers have never seen before…

It has a head start on every other American cannabis company…

It’s profitable and has been for years…

And it’s here in this report for your eyes only…

Releaf at Last

It’s called Trulieve Cannabis (OTC: TCNNF), and it’s one of my favorite companies in the marijuana sector.

Based in Florida, Trulieve is one of the very few profitable cannabis companies. It first turned a profit in 2017 and has kept profits growing ever since.

This isn’t some startup drowning in debt and relying on investors to keep afloat. In 2019, Trulieve brought in $252.8 million in revenue, a 145% increase over 2018’s revenue.

Net income was even more impressive. In 2019, Trulieve recorded net income of $178 million. It was an increase of 537%. By the end of 2019, the company’s basic earnings per share had grown by a factor of six, from $0.27 per share to $1.62.

Trulieve’s incredible growth has only continued into 2020. In the third quarter alone, Trulieve raked in $136.2 million in revenue, up 92.6% year over year. Only nine months into 2020, Trulieve eclipsed its full-year 2019 revenue, recording $353 million by September 30, 2020.

The company predicts it will bring in between $465 million and $485 million when the year is all said and done.

Those impressive financials come from Trulieve’s steady and aggressive expansion. The company has struck a great balance. It’s expanding quickly – but not so quickly that it overextends itself and collapses under its own weight.

It has 1.9 million square feet of cultivation space in Florida. The cannabis grown there goes through the company’s operations across six states.

Trulieve first reached beyond its native Florida in 2018 to expand to Massachusetts and California. In 2019, it moved into California. Just this year, it opened up shop in Pennsylvania and West Virginia.

Customers in California, Pennsylvania, Connecticut and Florida can buy Trulieve’s 500-plus unique products in 72 store locations. Those customers represent a market of more than $12.5 billion. And Trulieve is just getting started…

It already controls 52% of Florida’s cannabis market share. It’s also the first cannabis company to sell edibles in its native Florida.

The company has a dedicated customer base of nearly 400,000 people. And that’s in part due to its vertically integrated operations.

Trulieve is in full control of its products from seed to sale. Customers can trust they’re buying a high-quality product because the same company has handled it with care all along.

The company’s executive board is also a major factor in its success. The company has brought together a group of legal, business and cannabis experts with years of collective experience in each field.

Despite its success, Trulieve is still relatively small, but it punches well above its weight class.

Unlike other well-known cannabis companies, Trulieve hasn’t had large booms followed by busts. It has had steady and sustained growth – both in its business and in its share price – since it went public in 2018. Right now, it can be picked up for around $30 per share.

An Exclusive Pick for Your Eyes Only

In short, Trulieve is one of my favorite cannabis plays for 2021. It has smart leadership and great financial data, and it’s expanding in the right way to set itself up for future success.

It’s not on most investors’ radar right now, but it will be… and that’s what makes it such a great opportunity.

The vast majority of Americans currently live in a state where marijuana is legal in some form. Fifteen states and Washington, D.C., now allow for adult-use. At the same time, 36 allow for medical use, and 47 states allow for legal possession or some form of decriminalization.

So if you didn’t invest in cannabis in its early days and missed out on those gains, now is the time to get in.

Buy Trulieve now while it’s still small. Then you can ride the waves as cannabis moves closer to full, federal legalization.

This could be the cannabis blue chip of tomorrow, bringing you steady growth for years to come.

Here’s to high returns,

Matthew